G Michael Deeb
Overview
Explore the profile of G Michael Deeb including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
203
Citations
5383
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pinsky B, Khaja M, Yang B, Patel H, Kim K, Fukuhara S, et al.
JTCVS Open
. 2025 Mar;
23:34-43.
PMID: 40061554
Background: Visceral malperfusion is a serious complication of acute aortic dissection. Currently, diagnosis relies on signs of end-organ failure, which may be clinically obscure and delay crucial treatment. Objective: The...
2.
Puri R, Spencer J, Tchetche D, Van Mieghem N, Forrest J, Reardon M, et al.
J Soc Cardiovasc Angiogr Interv
. 2025 Mar;
4(1):102448.
PMID: 40061419
Background: The native aortic annulus for self-expanding transcatheter aortic valve replacement (TAVR) has variable ellipticity. A noncircular and underexpanded transcatheter aortic valve (TAV) may impact hemodynamic performance. This study aimed...
3.
Hawkins R, Hamilton B, Sukul D, Deeb G, Ailawadi G, Fukuhara S
Ann Thorac Surg
. 2025 Jan;
PMID: 39864774
Background: The cause of increased risk for reoperation after transcatheter aortic valve replacement (TAVR) vs prior surgical aortic valve replacement (SAVR) is poorly understood. This study evaluated the impact of...
4.
Modine T, Tchetche D, Van Mieghem N, Deeb G, Chetcuti S, Yakubov S, et al.
Circ Cardiovasc Interv
. 2024 Oct;
17(11):e014018.
PMID: 39421943
Background: Transcatheter aortic valve replacement (TAVR) is an alternative to surgery in patients with severe aortic stenosis, but data are limited on younger, low-risk patients. This analysis compares outcomes in...
5.
Ramlawi B, Deeb G, Mumtaz M, Bajwa T, Rovin J, Yakubov S, et al.
J Thorac Cardiovasc Surg
. 2024 Aug;
PMID: 39181441
No abstract available.
6.
Gondi K, Tam M, Chetcuti S, Pagani F, Grossman P, Deeb G, et al.
J Soc Cardiovasc Angiogr Interv
. 2024 Aug;
2(1):100530.
PMID: 39132542
Background: Aortic regurgitation (AR) is common and detrimental in patients with left ventricular assist devices (LVADs). Off-label use of transcatheter aortic valve replacement (TAVR) has emerged as a potential treatment...
7.
Propensity-Matched Outcomes Comparing TAVR in Bicuspid vs Surgery in Tricuspid Aortic Valve Stenosis
Deeb G, Yakubov S, Reardon M, Ramlawi B, Chetcuti S, Kleiman N, et al.
J Soc Cardiovasc Angiogr Interv
. 2024 Aug;
2(1):100525.
PMID: 39132531
Objective: To compare 1-year outcomes in patients at low surgical risk with bicuspid aortic valve stenosis (AS) following transcatheter aortic valve replacement (TAVR) and low-risk patients with tricuspid AS following...
8.
Makkinejad A, Monaghan K, Chen S, Wu X, Ling C, Kim K, et al.
Ann Thorac Surg
. 2024 Aug;
119(3):568-575.
PMID: 39102933
Background: We aimed to determine the effect of aortic annular enlargement on the midterm outcomes of aortic valve replacement surgery by comparing patients with the same-sized (≤23 mm) native aortic...
9.
Zahr F, Ramlawi B, Reardon M, Deeb G, Yakubov S, Song H, et al.
JACC Cardiovasc Interv
. 2024 Jul;
17(14):1667-1675.
PMID: 39048253
Background: Outcomes from transcatheter aortic valve replacement (TAVR) in low-surgical risk patients with bicuspid aortic stenosis beyond 2 years are limited. Objectives: This study aimed to evaluate 3-year clinical and...
10.
Khaleel I, Harris A, Seth M, Sukul D, Deeb G, Joseph M, et al.
JACC Adv
. 2024 Jun;
2(9):100641.
PMID: 38938726
Background: Prior studies of aortic valve replacement (AVR) in patients with normal-flow, low-gradient aortic stenosis (NF-LG AS) have demonstrated conflicting results regarding the survival benefit of AVR. Changes in quality...